Sibanye-Stillwater, South African Nuclear Energy Corporation Partner on Cancer Treatment Research

MT Newswires Live04-17

Sibanye-Stillwater (SBSW) said Friday it has partnered with the South African Nuclear Energy Corporation to research the creation of a radioactive palladium isotope from rhodium for targeted cancer therapies.

The partner organization will test the rhodium produced by the mining firm to ensure it meets manufacturing standards before creating the high-purity palladium, the company said.

The resulting radioactive material is currently used in localized tumor treatments to deliver radiation directly to affected areas while aiming to protect surrounding healthy tissue, Sibanye-Stillwater said.

A future phase of the collaboration will focus on developing additional nuclear medicine uses for rhodium along with other platinum group metals, it said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2628272203?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-17 17:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2628272203","market":"sh","top_or_hot":-1,"title":"Sibanye-Stillwater, South African Nuclear Energy Corporation Partner on Cancer Treatment Research","media":"MT Newswires Live","content":"<html><body><p> Sibanye-Stillwater (SBSW) said Friday it has partnered with the South African Nuclear Energy Corporation to research the creation of a radioactive palladium isotope from rhodium for targeted cancer therapies.</p><p>The partner organization will test the rhodium produced by the mining firm to ensure it meets manufacturing standards before creating the high-purity palladium, the company said.</p><p>The resulting radioactive material is currently used in localized tumor treatments to deliver radiation directly to affected areas while aiming to protect surrounding healthy tissue, Sibanye-Stillwater said.</p><p>A future phase of the collaboration will focus on developing additional nuclear medicine uses for rhodium along with other platinum group metals, it said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sibanye-Stillwater, South African Nuclear Energy Corporation Partner on Cancer Treatment Research</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSibanye-Stillwater, South African Nuclear Energy Corporation Partner on Cancer Treatment Research\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-04-17 17:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Sibanye-Stillwater (SBSW) said Friday it has partnered with the South African Nuclear Energy Corporation to research the creation of a radioactive palladium isotope from rhodium for targeted cancer therapies.</p><p>The partner organization will test the rhodium produced by the mining firm to ensure it meets manufacturing standards before creating the high-purity palladium, the company said.</p><p>The resulting radioactive material is currently used in localized tumor treatments to deliver radiation directly to affected areas while aiming to protect surrounding healthy tissue, Sibanye-Stillwater said.</p><p>A future phase of the collaboration will focus on developing additional nuclear medicine uses for rhodium along with other platinum group metals, it said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SBSW","symbol_name":"Sibanye Gold Limited","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2628272203","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2628272203","pubTimestamp":1776419906,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Sibanye-Stillwater  said Friday it has partnered with the South African Nuclear Energy Corporation to research the creation of a radioactive palladium isotope from rhodium for targeted cancer therapies.The partner organization will test the rhodium produced by the mining firm to ensure it meets manufacturing standards before creating the high-purity palladium, the company said.The resulting radioactive material is currently used in localized tumor treatments to deliver radiation directly to affected areas while aiming to protect surrounding healthy tissue, Sibanye-Stillwater said.A future phase of the collaboration will focus on developing additional nuclear medicine uses for rhodium along with other platinum group metals, it said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SBSW":"Sibanye Gold Limited","BK4188":"贵重金属与矿石"},"translate_title":"Sibanye-Stillwater，南非核能公司癌症治疗研究合作伙伴","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SBSW":1.5},"content_text":"Sibanye-Stillwater (SBSW) said Friday it has partnered with the South African Nuclear Energy Corporation to research the creation of a radioactive palladium isotope from rhodium for targeted cancer therapies.The partner organization will test the rhodium produced by the mining firm to ensure it meets manufacturing standards before creating the high-purity palladium, the company said.The resulting radioactive material is currently used in localized tumor treatments to deliver radiation directly to affected areas while aiming to protect surrounding healthy tissue, Sibanye-Stillwater said.A future phase of the collaboration will focus on developing additional nuclear medicine uses for rhodium along with other platinum group metals, it said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2628272203","isCrawlerRequest":true}